Home » Topics » BioWorld Science

BioWorld Science
RSS

Ustekinumab efficacy demonstrated in pediatric Crohn's disease patients

May 12, 2020

Enrollment underway for first-in-human study of BRAF inhibitor ABM-1310 in advanced solid tumors

May 12, 2020

Canakinumab studied in phase III for CRS in patients with COVID-19-induced pneumonia

May 12, 2020

Boehringer Ingelheim studies BI-456906 for type 2 diabetes in new phase II trial

May 12, 2020

Kiniksa reports data on mavrilimumab for COVID-19 and vixarelimab for pruritus

May 12, 2020

Phase III study of mavacamten in obstructive hypertrophic cardiomyopathy meets endpoints

May 12, 2020

ONSET-2 trial of OC-01 in dry eye disease meets primary endpoint

May 12, 2020

New POLG genetic variant found in SANDO syndrome

May 12, 2020

Via gene therapy, follistatin fights fat's fallout

May 12, 2020

Dual adenosine A2A/A2B receptor antagonists described by Merck KGaA

May 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...